INANO SHOJIRO

イナノショウジロウ | INANO SHOJIRO

Affiliation and department：
Job title： Program-Specific Assistant Professor

Research field (1)： Tumor diagnostics and therapeutics

Research keywords (5)： molecular-targeted therapy , ubiauitination , bioPROTAC , Adeno-associated virus vector , Exosome

Research theme for competitive and other funds (4)：

2023 - 2025 Elucidation of the pathogenesis and development of disease-modifying therapies targeting neurodegenerative disorders by proteolytic system
2022 - 2024 活性化型KRASの特異的分解による膵癌新規治療法を創る
2019 - 2023 骨髄液エクソソームにフォーカスした低リスクMDSの造血不全の病態解明と、治療応用
2019 - 2021 Establishment of new cancer treatment targeting Intracellular molecules via extracellular vesicles

Papers (17)：

Seigi Oshima, Shojiro Inano, Gen Honjo, Sumie Tabata, Masakazu Fujimoto, Hironori Haga, Toshiyuki Kitano. A Case of Spontaneous Regression of Adult Multi-system Langerhans Cell Histiocytosis Presenting as Liver Tumor Rupture. Internal medicine (Tokyo, Japan). 2024
Seigi Oshima, Shojiro Inano, Toshiyuki Kitano. Epstein-Barr-Virus-Related Lymphoproliferative Disorder in a Patient With Primary Myelofibrosis: A Case Report and Literature Review. Cureus. 2024. 16. 3. e56586
Mitsuhiro Shimada, Shojiro Inano, Toshiyuki Kitano. T-cell lymphoma associated with dupilumab. Annals of hematology. 2023. 102. 6. 1601-1602
Sho Shibata, Yoko Takiuchi, Naoto Kawasaki, Yoshio Okamoto, Shojiro Inano, Akiko Fukunaga, Sumie Tabata, Ayako Arai, Ken-Ichi Imadome, Toshiyuki Kitano. NK-cell post-transplant lymphoproliferative disease successfully treated by second allogenic hematopoietic stem cell transplantation in chronic active Epstein-Barr virus infection. International journal of hematology. 2022. 115. 4. 595-599
Sho Shibata, Shojiro Inano, Mizuki Watanabe, Kensuke Fujiwara, Hiroo Ueno, Yasuhito Nannya, Junya Kanda, Naoto Kawasaki, Yoshio Okamoto, Yoko Takiuchi, et al. Identification of an asymptomatic Shwachman-Bodian-Diamond syndrome mutation in a patient with acute myeloid leukemia. International journal of hematology. 2022. 115. 3. 428-434

ｍore...

MISC (18)：

島田充浩, 大島正義, 田邉万璃子, 河崎直人, 岡本吉央, 高橋慧, 稲野将二郎, 坂本宗一郎, 田端淑恵, 北野俊行. 二次性巣状分節性糸球体硬化症をきたした真性多血症. 臨床血液. 2023. 64. 2. 151-151
島田充浩, 土井究, 河崎直人, 岡本吉央, 高橋慧, 稲野将二郎, 田端淑恵, 北野俊行. Dupilumab投与後に発症したT細胞リンパ腫. 臨床血液. 2022. 63. 8. 937-937
土井究, 河崎直人, 岡本吉央, 島田充浩, 高橋慧, 稲野将二郎, 饗庭明子, 田端淑恵, 北野俊行. バーキットリンパ腫と類似した骨髄スメア像を呈した肺小細胞がんの1例. 臨床血液. 2022. 63. 8. 939-939
土井究, 稲野将二郎, 河崎直人, 岡本吉央, 柴田翔, 瀧内曜子, 饗庭明子, 田端淑恵, 北野俊行. 著明な低フィブリノゲン血症を伴った多発性骨髄腫の1例. 臨床血液. 2021. 62. 9. 1429-1429
岡本吉央, 瀧内曜子, 河崎直人, 柴田翔, 稲野将二郎, 田端淑惠, 饗庭明子, 北野俊行. COVID-19に続発した広域反応性寒冷凝集素による溶血性貧血の一例(A case of hemolytic anemia secondary to COVID-19 with wide range cold agglutinins). 日本血液学会学術集会. 2021. 83回. PS-10

ｍore...

Patents (1)：

Books (1)：

Lectures and oral presentations (2)：

Novel Fanconi Anemia E3 Ligase RFWD3 / FANCW Promotes Removal of Both RPA and RAD51 During ICL Repair/HR
(2016)
Novel Fanconi Anemia E3 Ligase RFWD3 / FANCW Promotes Removal of Both RPA and RAD51 During ICL Repair/HR
(FARF Scientific Symposium 2016)

Education (2)：

Work history (7)：

2024/04 - 現在 Kyoto University, Graduate school of Medicine Department of Early Clinical Development Program-specific Associate Proessor
2023/12 - 2024/03 Kyoto University Hospital Hematology and Oncology Program-specific Associate Proessor
2022/07 - 2023/11 Tazuke Kofukai Foundation, Medical Research Institute Department of Hematology
2019/07 - 2022/06 Tazuke Kofukai Foundation, Medical Research Institute Kitano Hospital Department of Hematology
2017/07 - 2019/06 Kansai Electric Power Hospital Department of Hematology

Show all

Awards (1)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page